On May 21, 2021, TSD Life Sciences Co.,Ltd. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12,360 KRW | -3.74% | -0.64% | -8.58% |
1st Jan change | Capi. | |
---|---|---|
-8.58% | 209M | |
-20.55% | 10.82B | |
+47.97% | 3.25B | |
-32.75% | 2.11B | |
-14.15% | 2.08B | |
-26.06% | 1.48B | |
+19.85% | 1.02B | |
-2.62% | 733M | |
-31.67% | 391M | |
-43.88% | 383M |
- Stock Market
- Equities
- A217330 Stock
- News Cytogen, Inc.
- TSD Life Sciences Co.,Ltd. announced that it has received KRW 2.9999853 billion in funding from Cytogen, Inc.